Alicia Marie Jackson
Directeur Général chez Evernow, Inc.
Profil
Alicia Marie Jackson is the founder and current CEO of Evernow, Inc., which was founded in 2019.
She is also currently working as a Director at ImmuneBridge, Inc.
Postes actifs de Alicia Marie Jackson
| Sociétés | Poste | Début |
|---|---|---|
Evernow, Inc.
 Evernow, Inc. Medical/Nursing ServicesHealth Services Evernow, Inc. provides women health care services. The firm offers hot flashes, weight gain, brain fog, sleep problems, vaginal dryness, mood swings, fatigue, night sweats and urgent peeing services. The company is headquartered in San Francisco, CA. | Directeur Général | 01/01/2019 |
ImmuneBridge, Inc.
 ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Evernow, Inc.
Evernow, Inc. Medical/Nursing ServicesHealth Services Evernow, Inc. provides women health care services. The firm offers hot flashes, weight gain, brain fog, sleep problems, vaginal dryness, mood swings, fatigue, night sweats and urgent peeing services. The company is headquartered in San Francisco, CA. | Health Services |
ImmuneBridge, Inc.
ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018. | Health Technology |
